HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

An IL-13 promoter polymorphism associated with liver fibrosis in patients with Schistosoma japonicum.

Abstract
The aim of this study was to determine whether two polymorphisms in the gene encoding IL13 previously associated with Schistosoma hematobium (S. hematobium) and S. mansoni infection are associated with S. japonicum infection. Single nucleotide polymorphisms (SNPs) rs1800925 (IL13/-1112C>T) and rs20541 (IL13R130Q) were genotyped in 947 unrelated individuals (307 chronically infected, 339 late-stage with liver fibrosis, 301 uninfected controls) from a schistosomiasis-endemic area of Hubei province in China. Regression models were used to evaluate allelic and haplotypic associations with chronic and late-stage schistosomiasis adjusted for non-genetic covariates. Expression of IL-13 was measured in S. japonicun-infected liver fibrosis tissue and normal liver tissue from uninfected controls by immunohistochemistry (IHC). The role of rs1800925 in IL-13 transcription was further determined by Luciferase report assay using the recombinant PGL4.17-rs180092 plasmid. We found SNP rs1800925T was associated with late-stage schistosomiasis caused by S. japonicum but not chronic schistosomiasis (OR = 1.39, 95%CI = 1.02-1.91, p = 0.03) and uninfected controls (OR = 1.49, 95%CI = 1.03-2.13, p = 0.03). Moreover, the haplotype rs1800925T-rs20541C increased the risk of disease progression to late-stage schistosomiasis (OR = 1.46, p = 0.035), whereas haplotype rs1800925C-rs20541A showed a protective role against development of late-stage schistosomiasis (F = 0.188, OR = 0.61, p = 0.002). Furthermore, S. japonicum-induced fibrotic liver tissue had higher IL13 expression than normal liver tissue. Plasmid PGL4.17-rs1800925T showed a stronger relative luciferase activity than Plasmid PGL4.17-rs1800925C in 293FT, QSG-7701 and HL-7702 cell lines. In conclusion, the functional IL13 polymorphism, rs1800925T, previously associated with risk of schistosomiasis, also contributes to risk of late-stage schistosomiasis caused by S. japonicum.
AuthorsXin Long, Qian Chen, Jianping Zhao, Nicholas Rafaels, Priyanka Mathias, Huifang Liang, Joseph Potee, Monica Campbell, Bixiang Zhang, Li Gao, Steve N Georas, Donata Vercelli, Terri H Beaty, Ingo Ruczinski, Rasika Mathias, Kathleen C Barnes, Xiaoping Chen
JournalPloS one (PLoS One) Vol. 10 Issue 8 Pg. e0135360 ( 2015) ISSN: 1932-6203 [Electronic] United States
PMID26258681 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • IL13 protein, human
  • Interleukin-13
Topics
  • Adult
  • Animals
  • Case-Control Studies
  • Disease Progression
  • Female
  • Gene Expression
  • Haplotypes
  • Host-Parasite Interactions
  • Humans
  • Interleukin-13 (genetics, metabolism)
  • Liver (metabolism, parasitology, pathology)
  • Liver Cirrhosis (complications, genetics, parasitology, pathology)
  • Male
  • Middle Aged
  • Odds Ratio
  • Polymorphism, Single Nucleotide
  • Promoter Regions, Genetic
  • Risk
  • Schistosoma japonicum (pathogenicity, physiology)
  • Schistosomiasis japonica (complications, genetics, parasitology, pathology)
  • Severity of Illness Index

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: